Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H24O2 |
Molecular Weight | 272.382 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@]23[H])C=C(O)C=C4
InChI
InChIKey=VOXZDWNPVJITMN-FPSMNIFISA-N
InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15+,16+,17+,18+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26716744Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6479318 | https://www.ncbi.nlm.nih.gov/pubmed/3899717
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26716744
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6479318 | https://www.ncbi.nlm.nih.gov/pubmed/3899717
Epiestradiol is an estradiol isomer with weak estrogenic activity.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL206 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12077849 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26716744
Rats were treated with 0.5mk/kg for 30 days
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
19669-82-0
Created by
admin on Sat Dec 16 10:01:41 GMT 2023 , Edited by admin on Sat Dec 16 10:01:41 GMT 2023
|
PRIMARY | |||
|
1BAQ18C647
Created by
admin on Sat Dec 16 10:01:41 GMT 2023 , Edited by admin on Sat Dec 16 10:01:41 GMT 2023
|
PRIMARY | |||
|
7061189
Created by
admin on Sat Dec 16 10:01:41 GMT 2023 , Edited by admin on Sat Dec 16 10:01:41 GMT 2023
|
PRIMARY | |||
|
m6482
Created by
admin on Sat Dec 16 10:01:41 GMT 2023 , Edited by admin on Sat Dec 16 10:01:41 GMT 2023
|
PRIMARY | Merck Index |
SUBSTANCE RECORD